Work

Table 1 from Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial

Year: 2026

Type: other

Abstract: Baseline demographic and disease characteristics (177Lu-FAP-2286 safety set, N = 27).

DOI: 10.1158/1078-0432.33403125

Authors: Jonathan McConathy, Vadim S. Koshkin, Yusuf Menda, Jordi Rodon, Ajit H. Goenka, Ryan H. Moy, Sophie Morse, Arnaud Demange, Lars Blumenstein, Burcu Babaoglan, Paola Aimone, Thomas A. Hope

Topic: Peptidase Inhibition and Analysis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7204951981

Cites:

Cited by:

Related to: